Jubilant

JUBLPHARMA.NS

Tags: IN Healthcare Drug Manufacturers - Specialty & Generic

Jubilant Pharmova Price (JUBLPHARMA.NS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

158,856,621

(0.1828)%

Market Cap of Jubilant (JUBLPHARMA.NS)

Market cap:

As of , JUBLPHARMA.NS has a market cap of . This makes JUBLPHARMA.NS the 390th most valuable company in the IN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Revenue and Profitability

Year	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Revenue	8,592,010,000	11,702,650,000	15,053,500,000	18,097,150,000	24,888,770,000	35,179,840,000	37,812,720,000	34,334,040,000	43,031,260,000	51,429,900,000	57,216,130,000	57,761,380,000	57,004,500,000	57,652,750,000	74,247,760,000	89,970,880,000	89,765,370,000	59,638,760,000	60,591,650,000	62,193,000,000	66,448,000,000
Net Income	782,370,000	1,191,930,000	1,296,750,000	2,280,000,000	4,004,940,000	2,831,760,000	4,214,610,000	2,297,190,000	145,610,000	1,527,270,000	1,090,400,000	-577,640,000	4,314,850,000	5,756,530,000	6,428,060,000	5,744,560,000	8,982,460,000	8,358,690,000	4,139,360,000	-609,800,000	771,000,000
FCF USD	843,140,000	1,116,720,000	-2,594,120,000	1,906,360,000	4,569,810,000	-1,096,880,000	4,021,040,000	-1,933,900,000	929,790,000	5,058,650,000	5,117,970,000	4,082,290,000	7,364,610,000	8,042,930,000	8,141,150,000	4,655,830,000	9,687,850,000	12,567,710,000	2,375,520,000	-1,537,800,000	736,000,000
OCF USD	843,140,000	1,116,720,000	141,820,000	1,906,360,000	4,569,810,000	5,580,640,000	7,096,050,000	3,880,550,000	7,075,400,000	9,699,840,000	8,026,050,000	7,832,600,000	10,922,980,000	12,684,870,000	13,032,000,000	11,215,110,000	15,429,380,000	17,842,650,000	8,375,430,000	6,606,700,000	9,713,000,000

Financial Health - DEBT

Year	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
YTPD	0.00	2.27	4.29	5.60	7.11	13.29	6.13	14.49	24.89	7.24	8.28	91.54	5.16	4.76	3.55	4.69	3.25	2.28	4.25	119.64	43.64
D/E	2.04	0.74	0.87	1.86	1.71	3.14	1.44	1.81	1.55	1.52	1.67	1.95	1.55	1.18	0.85	1.01	0.86	0.60	0.60	0.68	0.67
CA/CL	2.31	1.79	2.33	3.36	2.60	1.65	1.83	2.32	1.06	0.95	0.75	1.27	1.15	1.76	1.59	2.19	1.92	2.82	2.20	2.12	2.05
TA/TL	1.32	1.67	1.69	1.39	1.43	1.24	1.49	1.41	1.44	1.45	1.46	1.40	1.48	1.60	1.72	1.72	1.81	2.14	2.14	1.94	1.88
Total Debt	4,210,000,000	3,718,770,000	7,220,330,000	16,526,130,000	21,084,530,000	38,781,100,000	31,727,330,000	39,245,210,000	36,069,840,000	37,921,910,000	43,952,820,000	47,931,180,000	45,167,200,000	40,452,850,000	34,688,890,000	48,404,280,000	48,083,890,000	28,295,630,000	31,920,020,000	36,767,600,000	36,640,000,000

Management Performance

Year	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
ROIC	21.93%	18.83%	8.53%	10.74%	15.59%	10.09%	9.13%	5.21%	4.16%	6.04%	6.32%	-5.28%	8.78%	10.58%	10.18%	8.84%	8.48%	9.49%	6.17%	-8.99%	2.22%
ROE	38.00%	23.87%	15.70%	25.65%	32.43%	22.92%	19.15%	10.58%	0.62%	6.12%	4.15%	-2.35%	14.83%	16.75%	15.73%	11.95%	16.03%	17.63%	7.78%	-1.13%	1.42%
ROA	0.00%	13.00%	8.20%	9.11%	7.05%	4.49%	7.59%	3.18%	1.45%	4.05%	2.34%	0.47%	6.53%	8.16%	8.93%	7.88%	9.67%	13.59%	6.31%	0.25%	0.67%
NM %	9.11%	10.19%	8.61%	12.60%	16.09%	8.05%	11.15%	6.69%	0.34%	2.97%	1.91%	-1.00%	7.57%	9.98%	8.66%	6.38%	10.01%	14.02%	6.83%	-0.98%	1.16%
FCF / R%	0.00%	9.54%	-17.23%	10.53%	18.36%	-3.12%	10.63%	-5.63%	2.16%	9.84%	8.94%	7.07%	12.92%	13.95%	10.96%	5.17%	10.79%	21.07%	3.92%	-2.47%	1.11%
FCF / NI%	87.26%	68.04%	-154.28%	64.56%	154.09%	-36.98%	77.64%	-80.38%	81.48%	148.29%	246.91%	1,012.37%	126.03%	109.04%	94.77%	51.51%	80.03%	103.69%	37.68%	-553.56%	95.46%
Operating Margin (OM)	0.00	0.15	0.16	0.22	0.27	0.22	0.25	0.27	0.20	0.19	0.18	0.15	0.22	0.36	0.36	0.34	0.43	0.72	0.77	0.73	0.68

Per Share

Year	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
EPS	4.92	7.49	8.15	14.33	25.17	17.80	26.49	14.44	0.91	9.59	6.85	-3.63	27.12	36.18	40.40	36.10	56.39	52.48	26.01	-3.83	4.86
SPS	53.99	73.54	94.60	113.73	156.41	221.08	237.62	215.76	270.16	322.89	359.21	362.98	358.23	362.30	466.59	565.40	563.57	374.46	380.66	390.79	419.21
OCPS	5.30	7.02	0.89	11.98	28.72	35.07	44.59	24.39	44.42	60.90	50.39	49.22	68.64	79.71	81.90	70.48	96.87	112.03	52.62	41.51	61.28
FCPS	5.30	7.02	-16.30	11.98	28.72	-6.89	25.27	-12.15	5.84	31.76	32.13	25.65	46.28	50.54	51.16	29.26	60.82	78.91	14.92	-9.66	4.64
BVPS	13.18	31.70	52.84	56.94	78.94	79.66	140.72	139.14	150.60	163.60	174.81	154.18	182.84	213.46	253.57	302.21	351.83	297.71	334.00	338.79	342.01

Per Share - CAGR

Year	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
CAGR-EPS	4.92	7.49	8.15	14.33	25.17	17.80	26.49	14.44	0.91	9.59	6.85	-3.63	27.12	36.18	40.40	36.10	56.39	52.48	26.01	-3.83	4.86
CAGR-SPS	53.99	73.54	94.60	113.73	156.41	221.08	237.62	215.76	270.16	322.89	359.21	362.98	358.23	362.30	466.59	565.40	563.57	374.46	380.66	390.79	419.21
CAGR-OCPS	5.30	7.02	0.89	11.98	28.72	35.07	44.59	24.39	44.42	60.90	50.39	49.22	68.64	79.71	81.90	70.48	96.87	112.03	52.62	41.51	61.28
CAGR-FCPS	5.30	7.02	-16.30	11.98	28.72	-6.89	25.27	-12.15	5.84	31.76	32.13	25.65	46.28	50.54	51.16	29.26	60.82	78.91	14.92	-9.66	4.64
CAGR-BVPS	13.18	31.70	52.84	56.94	78.94	79.66	140.72	139.14	150.60	163.60	174.81	154.18	182.84	213.46	253.57	302.21	351.83	297.71	334.00	338.79	342.01

Revenue $66.45B

+6.84%

10Y

Net Income $771.00M

-226.43%

10Y

Operating Cash Flow $9.71B

+47.02%

10Y

Free Cash Flow $736.00M

-147.86%

10Y

YTPD $43.64

-63.52%

10Y

D/E $0.67

-0.98%

10Y

CA/CL $2.05

-3.34%

10Y

TA/TL $1.88

-2.61%

10Y

ROIC $2.22%

-124.71%

10Y

ROE $1.42%

-225.63%

10Y

ROA $0.67%

+168.12%

10Y

Net Margin $1.16%

-218.34%

10Y

FCF / R% $1.11%

-144.80%

10Y

FCFNI % $95.46%

-117.24%

10Y

Operating Margin $0.68

-6.44%

10Y

EPS $4.86

-226.95%

10Y

SPS $419.21

+7.27%

10Y

OCPS $61.28

+47.61%

10Y

FCPS $4.64

-148.05%

10Y

BVPS $342.01

+0.95%

10Y

Wordpress Tutorials

eCommerce Website Tutorials

Responsive Design

Jubilant

Stock Price

Fetching Data...

Fetching Data...

Fetching Data...

158,856,621

Market Cap of Jubilant (JUBLPHARMA.NS)

Market cap:

Year

Beginning Of Year

End Of Year

YOY Change

Revenue of Jubilant (JUBLPHARMA.NS)

Revenue:

Year

Revenue

YOY Change

Net Income of Jubilant (JUBLPHARMA.NS)

Net Income:

Year

Net Income

YOY Change

Free Cash Flow of Jubilant (JUBLPHARMA.NS)

Free Cash Flow:

Year

FreeCash flow

YOY Change

Operating Cash Flow of Jubilant (JUBLPHARMA.NS)

Operating Cash Flow:

Year

Operating Cashflow

YOY Change

Return on Invested capital of Jubilant (JUBLPHARMA.NS)

Return on Invested capital: %

%

Year

Return on Invested Capital

YOY Change

Return on Equity of Jubilant (JUBLPHARMA.NS)

Return on Equity: %

%

Year

Return on Equity

YOY Change

Return on Assets of Jubilant (JUBLPHARMA.NS)

Return on Assets: %

%

Year

ROA

YOY Change

Total debt of Jubilant (JUBLPHARMA.NS)

Total debt:

Year

MarketCap

YOY Change

Marketing Budget of Jubilant (JUBLPHARMA.NS)

Marketing Budget:

Year

MarketCap

YOY Change

Employee of Jubilant (JUBLPHARMA.NS)

Employee:

Year

Employees Number

YOY Change

Payroll of Jubilant (JUBLPHARMA.NS)

Payroll:

Year

Payroll

YOY Change

Dividends of Jubilant (JUBLPHARMA.NS)

Dividends:

Year

Dividends

YOY Change

Executive Compensation of Jubilant (JUBLPHARMA.NS)

Executive Compensation: